Case 2: Management of False Positive UDS- Enduring
Note: This is not registration for the live webinar. This is registration for the enduring recorded course.
RECORDED OPIOID SAFETY GRAND ROUND: Registration opens and course begins June 23, 2023
Management of the False Positive UDS is a recorded opioid safety grand round that will provide standardized, comprehensive, easily accessible, evidence-based education on best practices and current laws regarding opioids for professionals throughout the State. This 1 RECORDED case study focuses on urine drug screen (UDS) tests associated with chronic pain management, the factors that put chronic pain patients as persons at risk of opioid use disorder, UDS monitoring for safe practice management, and how to interpret UDS aberrancy for false negative UDS s/p low opioid dosing, false positives, and improper test handling.
TARGET AUDIENCE: New Jersey Physicians; Podiatrists; Physician Assistants; Certified Nurse Midwives; Dentists; Advanced Practice Nurses; Social Workers; Psychologists; Marriage & Family Therapists; Professional Counselors; Athletic Trainers; Dentists; and Pharmacists.
AVAILABLE CREDIT FOR PHYSICIANS: 1 AOA Category 1-B and 1 AMA PRA Category 1 credit™
BOARDS WHO RECOGNIZE THESE COURSES:
- Board of Medical Examiners
- Physician Assistant Advisory Committee
- Board of Nursing
- Board of Dentistry
- Board of Pharmacy
To receive full credit, you must be present for the entire live webinar.
To receive a certificate of completion, and CME certificate, complete the Attestation Form, and Outcome Survey/Evaluation, Knowledge Assessment.
Hearing Impaired Registrants: This enduring course will contain closed captioning.
For questions pertaining to AOA and ACCME CME credits, please contact CME office at cme@rowan.edu
For technical support with registration and access to the module, please contact the Rowan Online Marketplace Center submit an email ticket here.